↓ Skip to main content

Dove Medical Press

MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689

Overview of attention for article published in Drug Design, Development and Therapy, January 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
14 Mendeley
Title
MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689
Published in
Drug Design, Development and Therapy, January 2019
DOI 10.2147/dddt.s186352
Pubmed ID
Authors

Hui Zeng, Jiaping Zheng, Song Wen, Jun Luo, Guoliang Shao, Yongjun Zhang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 14%
Student > Ph. D. Student 2 14%
Student > Doctoral Student 2 14%
Lecturer 1 7%
Student > Bachelor 1 7%
Other 1 7%
Unknown 5 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 21%
Medicine and Dentistry 3 21%
Immunology and Microbiology 1 7%
Unknown 7 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2021.
All research outputs
#8,525,675
of 25,372,398 outputs
Outputs from Drug Design, Development and Therapy
#640
of 2,267 outputs
Outputs of similar age
#159,630
of 444,049 outputs
Outputs of similar age from Drug Design, Development and Therapy
#10
of 33 outputs
Altmetric has tracked 25,372,398 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,267 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,049 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.